Web: http://arxiv.org/abs/2109.12769

Sept. 22, 2022, 1:12 a.m. | Yaobin Ling, Pulakesh Upadhyaya, Luyao Chen, Xiaoqian Jiang, Yejin Kim

cs.LG updates on arXiv.org arxiv.org

Developing new drugs for target diseases is a time-consuming and expensive
task, drug repurposing has become a popular topic in the drug development
field. As much health claim data become available, many studies have been
conducted on the data. The real-world data is noisy, sparse, and has many
confounding factors. In addition, many studies have shown that drugs effects
are heterogeneous among the population. Lots of advanced machine learning
models about estimating heterogeneous treatment effects (HTE) have emerged in
recent …

application arxiv benchmark healthcare machine machine learning treatment tutorial

More from arxiv.org / cs.LG updates on arXiv.org

Postdoctoral Fellow: ML for autonomous materials discovery

@ Lawrence Berkeley National Lab | Berkeley, CA

Research Scientists

@ ODU Research Foundation | Norfolk, Virginia

Embedded Systems Engineer (Robotics)

@ Neo Cybernetica | Bedford, New Hampshire

2023 Luis J. Alvarez and Admiral Grace M. Hopper Postdoc Fellowship in Computing Sciences

@ Lawrence Berkeley National Lab | San Francisco, CA

Senior Manager Data Scientist

@ NAV | Remote, US

Senior AI Research Scientist

@ Earth Species Project | Remote anywhere

Research Fellow- Center for Security and Emerging Technology (Multiple Opportunities)

@ University of California Davis | Washington, DC

Staff Fellow - Data Scientist

@ U.S. FDA/Center for Devices and Radiological Health | Silver Spring, Maryland

Staff Fellow - Senior Data Engineer

@ U.S. FDA/Center for Devices and Radiological Health | Silver Spring, Maryland

Computational Linguist

@ Constant Contact | Waterloo, ON/Hybrid, ON

Senior Data Scientist

@ Advian | Espoo, Finland

Data Scientist, EU In-stock Management

@ Gopuff | London, England